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Abstract The complete primary structure of a novel human 
laminin a4 chain was derived from eDNA clones. The translation 
product contains a 24-residue signal peptide preceding the mature 
a4 chain of 1792 residues. The domain structure is similar to that 
of the recently described a3 chain [Ryan, Tizard, Van Devanter 
and Carter (1994) J. Biol. Chem. 269, 22779-227871. Northern 
analysis of RNA from human fetal and adult tissues revealed 
developmental regulation of expression. In adult, strong expres- 
sion was observed in heart as well as lung, ovary, small and large 
intestines, placenta and liver, whereas weak or no expression was 
detected in skeletal muscle, kidney, pancreas, testis, prostate or 
brain. In contrast, fetal lung and kidney revealed high expression. 
In situ hybridization analysis of human fetal and newborn tissues 
showed expression of the laminin in or4 chain in certain mesenchy- 
mal cells in tissues such as smooth muscle and dermis. 
Key words; Basement membrane; Extracellular matrix; cDNA 
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1. Introduction 
The laminins are a complex family of extracellular matrix 
proteins, each comprising three subunit polypeptide chains [1 
5]. These chains, which are classified as c~, fl and 7/ types, 
associate through a triple-helical coiled coil forming a cross- 
shaped molecule with an ~80 nm long rigid rodlike structure 
and two or three shorter arms. To date, the primary structure 
of seven genetically distinct laminin chains, ~1, ~2, ~3, i l l ,  f12, 
f13, 7/1 and 7/2 has been determined from man [6-16]. Also the 
sequence of the ~zl, fll and 7/1 chains from mouse [17-19] and 
Drosophila [20-23], and that of the rat laminin t2  chain have 
been reported [24]. Evidence for two additional c~ chains has 
also been presented [25,26]. The different laminin chains share 
a certain degree of homology which includes domains with 
globular structures, rod-like domains containing EGF-like re- 
peats, and domains participating in the coiled coil of the long 
arm. Additionally, the c~ chains contain a large C-terminal 
globular domain with five internal repeat motifs that share 
homology with corresponding motifs in perlecan [27,28], agrin 
[29], neurexins [30], Drosophila crumbs protein and the sex- 
hormone binding globulin [31]. 
The different laminin subunit chains differ extensively with 
respect o their distribution in vivo which suggests tissue-spe- 
cific functions. Numerous physiological functions have been 
proposed for laminins (for review, see [32]), but the roles of 
different isoforms are still largely unknown. However, recent 
data on two inherited iseases involving laminin gene defects 
have shed some light on the function of two isoforms. In epider- 
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molysis bullosajunctionalis, a skin blistering disease, mutations 
were described in the human gene (LAMC2) for the 7/2 chain 
[33,34] demonstrating that this hemidesmosomal protein is es- 
sential for attachment of epithelial cells. A mutation was re- 
cently also described in the gene for the c~2 chain (LAMA2) [35], 
in dy mice with muscular dystrophy, indicating that this chain 
is important for differentiation or function of muscle fibers. 
Although the protein defect resides in the short arm structures 
in these cases, much of the cellular effects of laminins are 
thought to be mediated through the proteolytic E8 fragment 
comprising about 60% of the globular G domain of the ~ chain 
and a segment of the trimeric coiled coil. For example, this 
fragment is recognized by the integrin cell surface receptors 
0~6fll [36], ~3fll [37], c~7fll [38] and ~6fl4 [39]. 
In the present study we report the cloning and the cDNA- 
derived primary structure of a fourth human laminin ~ chain, 
termed ~4. Expression of this chain was examined in human 
tissues by Northern analysis and in situ hybridization tech- 
niques. 
2. Experimental 
2.1. Isolation and characterization f cDNA clones 
A human fetal ung library in the 2gt 11 cloning vector (Clontech) was 
screened using standard techniques [40] with a PCR product obtained 
from the same library using primers 5'agtaagcttgccactccttcaY and 
5'tccaggatcctgacatgacaga3' (see Fig. 2). These primers were designed 
based on two GenBank sequence ntries X70904 and Z24848 encoding 
a laminin-like protein. All primers in this study were synthesized using 
DNA/RNA synthesizer model 392 (Applied Biosystems). Clone FL64 
was chosen for further analysis and subsequently used as a probe to 
rescreen the library. In this manner a series of overlapping cDNA 
clones were identified and subcloned into pBluescriptII.SK- or pCRSS- 
cript vectors (Stratagene) for sequencing by the chain termination 
method [41] using a T7 sequencing kit (Pharmacia). All sequence anal- 
ysis was carried out using the GCG software [42]. 
2.2. Northern analysis and in situ hybridization 
For Northern analysis filters containing RNA from several human 
tissues (Clontech) were hybridized with the following probes: nucleo- 
tides 4600 to 5681, 190 to 1249 and fl-actin as a control (see Fig. 2). 
For in situ hybridization, a PCR product from primers 5'ag- 
taagcttgccactccttca3' and 5'tccaggatcctgacatgacaga3' (nucleotides 
5440-5681) was digested with HindIII, and the 106 bp HindIII fragment 
was ligated into the pGEM-3Z vector for the production of single 
stranded RNA probes in both orientations. In situ hybridization alaysis 
was carried out on 20-week-old human fetal and neonatal tissues ac- 
cording to Cox et al. [43] with minor modifications a described earlier 
[11]. 
3. Results and discussion 
3.1. Primary and domain structure of the laminin o~4 chain 
Five overlapping cDNA clones isolated and characterized in
this study (Fig. 1) together covered a total of 6204 nucleotides, 
including 190 bp of a 5' UTR and 566 bp of a 3' UTR regions, 
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Fig. I. Illustration of cDNA clones for the laminin c~4 chain and domain structure of laminin c~ chains. (Top) Scale in base pairs (bp) and alignment 
of five overlapping cDNA clones with partial restriction map. Restriction enzyme sites SacI (S) and HindIII (H) are shown. (Bottom) Domain 
structure of the human laminin c~4 chain and comparison with that of the ~3, c~l and ~2 chains. Five internal repeats of domain G are indicated 
by light boxes, and cysteine-rich EGF modules of domains IIIa, IIIb and V are depicted by dark boxes. Scale in amino acids (aa) is shown beneath. 
respectively. The open reading frame of 5448 nucleotides (Fig. 
2) coded for a laminin s-type chain, characterized by the pres- 
ence of a G domain with five internal repeat motifs. We refer 
to this chain as the laminin ~4 chain, as it was first proposed 
by Richards et al. who localized the LAMA4 gene to 6q21 [25]. 
There are two in-frame ATG codons for methionine in the 5' 
region of the FL136 clone, one at position -149 (see Fig. 2) and 
the other tentative initiation codon at position 1. We consider 
the latter ATG codon to represent the translation start site for 
the following reasons. First, the sequence around the second 
ATG is in agreement with the consensus sequence of Kozak's 
[44]. Secondly, the predicted sequence of the first 24 residues 
are characteristic of a signal peptide which is present in all other 
laminin chains, and thirdly, the amino acid sequence around 
position 24 is characteristic for a signal peptidase cleavage site 
as described by von Heijne [45]. In addition, there is an out of 
frame ATG at position -14, but the corresponding open read- 
ing frame covers only seven amino acid residues. Nevertheless, 
this ATG codon could regulate the initiation of translation as 
discussed by Kozak [46]. The calculated mass of the entire 
translation product is 201,964, and that of the processed ~4 
chain 199,306. 
Comparison with the sequence of other human laminin 
chains revealed that the domain structure of the ~4 chain re- 
sembles more that of the ~3 chain [13], than of the ~1 and ~2 
chains (Fig. 1) [10,14]. The ~4 is slightly larger the human c~3 
chain which has 1713 residues, but both chains are significantly 
smaller than the ~1 and c~2 chains which contain 3075 and 3110 
residues, respectively. The C-terminal G-domain of ~4 has five 
repeat motifs as the other laminin ~ chains. It shares 25.6% and 
36.0% sequence identities with corresponding domain of the c~l 
and ~3 chains, respectively. The coiled coil domain I/II, that 
forms the long arm, has a primary structure with heptad repeats 
similar to that in the other laminin chains (not shown). While 
the short arms of ~1 and ~2 chains contain three globular 
subdomains separated by three rod-like structures, the ~4 chain 
short arm has only one rod-like segment preceded by a short 
N-terminal domain (Fig. 1). The rod-like segment is composed 
of three complete EGF-like repeats flanked by incomplete re- 
peats. This sequence shows closest homology to the domain 
Fig. 2. cDNA nucleotide and derived amino acid sequence for the human laminin ~4 chain. First line, nucleotide s quence; second line, deduced amino 
acid sequence. The translation stop codon TGA is indicated by an asterisk and three potential polyadenylation signals (AATAAA) are underlined. 
The putative signal peptidase cleavage site is indicated by a triangle (A). The cysteine residues are circled, and potential attachment sites for 
asparagine-linked oligosaccharides areboxed. 
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-190 ta  0 s ~  atao0~et  ~t t~.gat  goagtac~at  ~g0t t  qegoaeg~ -121 
-120 t o g g g a t a e t g G a c ~ l a g g a g & g g a O g g a a a & t a a g a g a g ~ ~ c ~ I g a ~ a q w a a ~ g ~ a a ~ a ~ a t ~ g ~ g a g a a  -1 
i at ggettt gag~aag~ggogc : t~gt t~~ot~a --~-~.~g~oga=aaog~tttt o~tttga~attgaagggag~ 120 
1 M A L s s a w R a V L P L W 1. L if g & k ~ S R ~A 8 Q D D N A • P • D I I ~ s s 40 
121 gcggt tggcaggQaaga~e~gagsog&gog&a~ggot~~~g~a~t~tt~t~~ggagaat~g 240 
41 A V G • Q D P • • T S • • n V ~ L a R 1. • • a A • ¢ ~ m ~ a • • x 'r 1. s G I ~ v  80 
241 ~cct~coact~t  a a t  ggcaat t  ¢~-a oGaOt~t1~Igaoggat  ~ILqgat a G 1 : ~ d ~ ~ ~ g a ~ a a a a ~ q a t  g~t  a t  a t  ~ga  gat  360 
01 P ~ D ~ N  
481 ta tgct~ga~taa~c~aaa~at~-~-~tac~c~r~aaa~t~c~at t~g1ta~&&~~g~aat t~t~ga~ttg  aa 600 
161 Y A G P M ~ • R ~ A • G Y T G M P • L Z G • T ~ E  K ~ D ~ •  G M • D P J L Z • • 200 
601 ~at  t~ Oat g aa01~ ~:goea0~a~gaat t .~ l~1:a  art ~aagt~aogt t i~g¢: t~tat  ggggaogaoaggatag~c~aagaa~t ot g~agt g 720 
721 t~caac~g~a~gccc~t~[~a~a~q~aa~c~a~aa~a~a&~tt~a~a~ataa~~&~8~&~a~ 040 
841 gc~t  c~ccat  c~a ggaagg~aa at~g~c~a ~ a t  ~ l :~*~gu~qat  eat~q~aat  ~ ~ t  ~ a ~ a a a  ~aaat t  ~ a a  960 
281 A L 9 Z • • G K • G V L • V • • G A A k H • • v • It Z IM A TJ Z Y L 1. g T I[ L • • 320 
961 agaGaa accaat  ac~ctaa~a~ata~aaat~aa~aat~c~t~a~a~a~gat~aaaa~t~:~a~a~a~aa~auat~a~qaaaa~a 1080 
321 R • N ~ Y A L • g Z Q I M M A • M T M • • L L • D V • • L V • K • N Q A 8 R K G 360 
1081 caac~ct g t t  cagaagga&&g~tgga~ac~ttaa~a~G~aa~1~a~T~&~~ta%g~ta&~at~8~&t~a~a~a~atg~&ttatg~ aa 1200 
361 Q L V ~ K • 8 M D T Z N ~ A • g L V • g A • D M • D E Z Q • Z M M • M 1. Y Y • • 400 
1201 gag~at  gaact tag~a0~&aat  c1~c~:0&~aaOc~:~O1:gt~GaaOa~a~0a~a~&~a~tt~t~a~&~Ogat~a~ga~ 1320 
401 • • • L • • • • Z • • X 1. V 1. A Q g M L • • l • • • ~ • • • T ~ R • L V D • • A 440 
1321 gat  ga gg~t  a o([a a~c aat  ga~o~a 0~ot~qlt ~a~ ~ q ~ ~ ~ ~ t  ~ ~ a ~ g ~ a ~ a t  g~aa~t  ~o~at  1440 
441 D • A Y • 1. 1. • ~ A • • M ~ R 1. M ~ • T L • • V V 1. • @ 1. D D Y M A K 1. B D 480 
1441 Ct c~ gga a~a ~t  t gac~a~gc~cf~ta &cn~at ~ a a g ~ t 4 ~ a & g & ~ ~ ~ ~  ~gaqaaa~a~g~aaqa~ ga gg~aa~&at  g 1560 
481 L Q • A L D ~ A L N Y V • D A • D M M R A T A A R ~ R D R • g O Q • • V • • ~ M 520 
1561 ~a a ~r t g01: g ~  ~g8 o~a~at~c0~fga~1~ot ~:~a~ &¢3a~oo~:aaot~d: tT~agaa~t  t  a t  aa~ ~ ~ g a t t  t a t  g~ga a &t a gat  g~a 1680 
s21 • v v ~. .~s]  1. • T • A n • - .  T T • n ,. • z. • • z, D n 2 x • I~ a •]  a x ~ ~ • z D ,, s6o 
1681 gocaaaa0t  gaactacaagt  aaaaotat~caaoa~aa~aa~_~___ .~ la~t ta0~aqaa~r .a~tga~ga~a~a~a~&~aat  gaa~g&g~gaa~ 1800 
561 A K S • b ~ V K 1. • l~ 1. • J IM 1. •l ~ D 1. V Q • & Z D K A O D 1. ~ O • A ~ • 1. S I~ K 600 
1801 t t  gcae~agttoagat a gaaeggg~ggta~agaagg~tttgga~goat~at~t~tatgaaaatatt~taattat~gaa~~g~qaattt g~t t aa~ 1920 
601 L H 8 S D M N G L V 0 K a L D a S • V T • N Z V N T V • • A ~X • T I A • • A 1. ~X T 640 
1921 a c tgacc~a t t ta t  ~atgc~O~ga~&~toata~aaa~oat t~ac~a%aaaga~aaa~gaqaa~a~gag&a~a~aa~a~ag~ 2040 
641 "~ D R Z Y D A V • O Z D T O Z Z Y E • D • • • M L 1. M ~ A It • 1. ~ A g A • 8 • 8 680 
601 D Z A V A D T 9 R • V Q G A L A • • • A 1. g T • L • D A V g Q 1. O A A • • G D A 720 
2161 cagcagc~cctggggca~rt  c tagac~gat  ca~aggaagc~aao~ac~ac~at~a~ag~aggcca~¢~t~g~a~at~aa~a~g~oaat  ~t~a 2280 
2201 ~att t t~ctc t t~t~ct taca~a~t~gt~t~c~c~g~pt~ma~aa~aaa~ga~~~t~t~a~g~a~g~ 2400 
961 H F D 9 II A Y M T A v M • A It D A V R IM 1. T I • V v • a 1. 1. n G '~ R T V • a g n 9 800 
2401 goaag~ a~Q~oagoatocag&~gatoo~aQaQ~d;c~t t~(M:~a~a~3a~raa~t~rt t~goaagato~as~I t~t  gat~t t~at  ~ g ~ g ~ g a a ~ c  2520 
801 A 9 ~N V 9J A 8 Z O ~ I R • 1. Z A Q T R • V A S K Z g V • M M • D G g 8 A V • V R 840 
2521 t c~aga8 cca~rt at ggat~acttaaao~cct~cao~ot~t(;ago(~g~aoat(;aaac~___~_ ~ r ~ a a ~ c ~ g ~ a a ~ a ~ a g a ~ a t ~ t t a ~ a c ~ a a ~ c  2640 
841 B R T B M D D L K A • T- • L 8 1. Y X g • • V K R • • L T • T A D ~ • Z L Y L G B 800 
881 K N A K K • Y M G L A Z g N D M L V Y V Y M 1. Q T • D V • I • 1. D S K 9 V 8 9 W 920 
2761 C~t gct t  a~t t  ~ag~-att  0~caagat tgaa&g~0~ggga&&a~g~aaa~tt taa~a~aa~a~a~&aa~t  ~t t  a&a&a~aat t~ 2880 
921 P A Y • 8 I V g Z • • V G K K G K V • L T V • S 1. • • T A • • • • Z ~ ~ a • • S 940 
2881 ~gagat  gactct  ct ~ct ~ga cot ggac=ct~ag~aoa~a~t~rt t t ta t~gtg~agtg~to~aac~toaagotc~ta~g~t  & a a ~ g ~ t t ~ t  g ~ a a  3000 
961 G D D S L L D L D P • D T V • Y V G G V D B M • • L • T B 1. • L 9 Q • V O ~ 1. g 1000 
3001 ct Ogccaott t  gaat  aat ~at ~rt ga~cagct t  ~r~a~a~tt t  aa~cusc~tc~at aa~at qga~.aoatoag~-at~goo~-~agat  &ag~t~gcct t  ~ g a ~  3120 
1001 L A T L N N D V I 8 L Y M • K H I Y • M b P B T 8 V P ~.~ A R D K L A • T Q 8 • A 1040 
3121 gcca gt t aot t ctt cgat gg~tccg~ttat  gcc~tg~tgagaga~at  accaaggagag~aaat t t  ggtcaggt~act~c~tt  gaoatagsagt to~aaca~ag~ga~a~gc~t  3240 
1041 A S Y F F D Q B G Y A V V R D Z ~ R R G K • G Q V T • • D Z • V • T 9 A D • G L i050 
3241 art ct oct gat g~t oaat~atgt t t  tt  caga~aaat  ~oaatg~tacota~atcr t~t t~at~at t t t~oat t r~go~t  g g ~ t ~ t ~ a a ~ a t  a~t  aaa ~ 3360 
1001 I L L M V IN @ 8] M • • R L • M R M G Y L R V • Y D • G • S 8 U R V R 1. • D T L K 1120 
1121 K A Q I N D A • Y R • I S Z Z Y • N D K • M I L V V D R R H V • S M D N • K M K 1160 
3481 at a cctt t t  acagat  &t at aca~t gga~ga~t  o~t~ca~&aat~ta=aatooag~gc~d~oa~a~ao~o~tt~sgat  a to~&ot toags~gat~at~&ag~ct t  ~ t  c 3600 
1161 I P r T D Z Y Z G O A P P • X L ~ 8 R A I. R A H 1. P 1. D Z M • • Q ~ M K G • ~ • 1200 
3601 ca aaaoa a~act t  caat t ta~a~oagaoa~aaacc~l~gagt tg~t ta t~oat~c~=a~aaga~tc~ct t  a ta to t~cagagcatat t t  caat  ~a~ga~t~ttg~t  ~ 3720 
1201 Q K • D • N L L • ~ T • T L G V Q Y Q ~ P • D • L Z 8 R R A Y • M g ~ 8 • Z A S 1240 
3721 at t caga aaatat  ctt tot  ~t~at~t tgaa~&g~tt t taa~t t (~R;aaoat ta~aac~aaatg~rt ta=tat tcd~at t  a tg~tcagg~rt~a~a~t~t~at  3840 
1241 I Q K Z B • • D Q • • G G • N • R T 1. O p M G L L • Y Y A 8 Q 8 D V • 8 I S L D 1280 
3841 ~ g t  C~t ~at g~&t ~r taaa~aat~aa&~r~t  ~ag1~o&~ta~&l~asg~a~-aoaat~at ~ g g ~ t o o o a o t t ~ t t a ~ ~ a ~ a ~ a t  ~aa~st  a 3960 
1281 [N a TJ V I M D V • • I I[ V ~ • V D K ~ Y M D • 1. 8 H • V I B B V B P T • Y • L Z 1320 
3961 gt  agat  aaaagcaga~tt  gggagtaagaatc~.~c~aa&~aa~atagaa~a~a~a~aag~aa¢r~g~aa~a&~tt t~t~~at~~tg~a~tt~ 4080 
1321 V D g B R v o , , ~ g . • z • o • g A 8 • • g • Y • . . • • z • A G Y A i ~ • 1360 
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4001 act  g~tgcataa~taatg~aat t taoea~gg~;~ata~aqatgt~ga~gt t~aa~at t t~:~a~aaaa~t~t~~tt~a~t~ 4200 
1361 "~ G ~ Z B N A Y • T • V D It D V • V • D • O R Y T • e V m t • L Y • ~  P Z • 8 8 1400 
4201 acat t  g~t t  a tc~tc~at  a a a a a a g ~ a a a a a a t t t a t o a a & g a ~ t a a a q o a ~ ~ ~ u ~ g a ~ t ~ t ~ a t ~ t ~ a ~  4320 
1401 P L • L L • lr ][ G lr  ~ s" • X A • Q If S. • G G lr • It" D A • 8 W D • V k L g L i' 1440 
.211,,1 1480"'° 
4481 ~tt t t~gtq~aa~tat~agt t~t~at t~gtc fcg~a~ta~c~a~at~t~t~t t~~t~t~~at t~t tg~gc  4560 
1481 D • ~; A 1¢ 6 Q • 6 Z • L • • • B • • G M Z • Y Y • D Q • • • D • M T L • L k I[ O 1520 
4551 r~+%~;g~tt  ao l l t  ; l ~ t t a l t o 1 : t O ~ t ~ I o l s a a a a ( ~ c g a l l g a ~ l g ~ u a ~ ~ ~ t q a t ~ a ~ t ~ t a t ~ a o a a a ~ a ~ Q g ~ a ~  4680 
1521 R L V Y X • N V • • If If L g Z • • Q • • Y N D G L l • D V Z • Z • • • I • • • L 1560 
4581 g ~ a t t g a t g g ~ a g t ~ a ~ a ~ g a ~ g ~ a ~ 4 ~ a ~ a ~ : q ~ t ~ t t ~ t t t ~ ~ a a a ~ a a a a t ~ t ~ g  4800 
1561 V l D G L St V L • • st L P I~ : • A 9 I • l • Q • l Y L Q G V l • G • A V i N V Q 1600 
4801 ar t  aact  cc~tc tacagt t t~ag~ggat~cd~cagcaat~tc~agcf~oaat~~t~qa~tt  ~ g a ~ t ~ g a a g g ~ t  ggaaa~ 4920 
1601 Z N • Z Y • • • G ~ ":" B • L Q L • Q ~. • X ~ B A • Q T • B V T • ~,,~ • • O • I( g T 1640 
4921 gOaa~'q~t a~c~tt  oaao lOaaOgaOOat  l o g l ; o o t t ~ a ~ I t g a a t o ~ t t o a l ~ t ~ a t ~ a ~ t ~ t ~ t t t q a a ~ ~ a ~ t ~ a a ~ o ~ o  5040 
1641 • T Y • • T • • G Y V V L D • g • • Z G L • • • Z A • • V • • • • • • G T L V • 1600 
5041 gq~a~a~a~t~F`F Jagt~a~t ; r t t :~a~aa~tQga~aG~t~t~~g~tt~~~g~ 5160 
1681 Q H 6 V N G • Y L • V R M g 1~ G Q V l V It" V X N G Z R D • • T • V T P g Q 6 L ~ 1720 
5161 ~at  ~ca~at  ggea~a~aat t  acagt ta t tagagat t~aatg~ggt tcagt tggatg~gga~gaa~gaa~t~g~a~g~t~aa l~at tgat~ag 5280 
1721 D g 1~ W H P. 1" T V l • D • • V V O L D V D • • V • • V V G • L N 5' • • Z D H P. • 1760 
5281 cc t  ~ .~t t  ~t tooaO; t  ~t  o~aoaatc t  ~ ¢ a c 1 ~ a a a c ~ a ~ - ~ g ~ g c a a a ~ x ~ t ~ ~ a ~ t ~ O a t ~ a a t a ~ o a o ~ t ~ a a a  5400 
1761 • V • V ~; 0 V 1, • I L L 9 • • L A • • g • • ~ O ~ Z • • • V l D ~; • • V " • S I[ 1000 
5401 ~ca~ccctgg~agcggc~cc~aagcat~act~g~n~tga~tga~g~g~g~aata~t~t tagaG~gaaa~aa~aag~g~g 5520 
1001 A A L V • Q k V 8 l N I; ~ 1' k k ~ 1816 
5521 a~aaca~rt  aact~t t¢~t~cqggtggaag~tt~at~gag~t~aaoa~aot taaaogaa~oat  a~a~gatat t t~t  a t t t ~ t ~ t ~ t a a ~ t q a a t ~ a a ~  5640 
5641 gt  c tgcaat  ogacaa~aat t  Oaaggagagq~aaacf~taot tq ta t t :~ Iaqagoa~at t~a~q~at ta~t t~t t  ~a~aaataqaa~g&~t~aataaac  5760 
5761 actt~a~c~ttttt~a~t~ta~att~t~atta~tt~t~g~a~a~aa~ttt~at~atataaa~t~aaaa~a~tt~ttattttgaagaga 5880 
5881 ~tt~ct~ct tacatataa~at~t ta~at~tagat t t¢ f~t t t ta~t t t tg t t tggtat~t~a~t~t~aatat t t t~t~t~aa~tat~a~ttaataaa  6000 
6001 g~aaat t tc taaca  6014 
Fig. 2. (continued). 
I I Ib of the al  chain with 49.3% sequence identity. Comparison 
with the domain III of the a3 chain reveals 46.3% sequence 
identity. 
3.2. Expression of the laminin a4 chain in human tissues 
Expression of the laminin c~4 chain was first studied for levels 
of mRNA using Northern analysis (Fig. 3). In human fetus a 
strong signal was observed with RNA from lung and a distinct, 
although somewhat weaker signal was also obtained with kid- 
ney RNA. No signals were observed in brain or liver RNA. In 
human adult RNA the strongest signal was observed in heart, 
somewhat weaker signals being observed for lung, ovary, pla- 
centa and liver. Furthermore, still weaker signals were obtained 
with RNA from small intestine, colon, skeletal muscle, kidney, 
A B 
/ 
Fig. 3. Northern analysis of the laminin ~4 chain with RNA from tissues. A, Fetal. B, Adult. Upper row: laminin ~4 chain (6.5 kb), bottom row: 
fl-actin. Note the inverse relationship of the laminin derived band intensities in kidney and liver (A vs. B). 
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Fig. 4. In situ hybridization of the laminin ~4 chain in 17-week-old human fetal tissues. In skin fold (A,B) expression is located in the dermis and 
subcutaneous fat. In brain (C,D), ependymal cells covering the ventricular surface show clear signals, whereas other egions of the brain tissue remain 
negative. The sense controls probes did not yield grain density above the negative control without probe (not shown). A and C, dark field; B and 
D, bright field. 
pancreas, testis and prostate. Brain RNA did not yield any 
signals above background. The changes in liver and kidney 
expression from fetal to adult stages probably reflect ight de- 
velopmental regulation of the ~1 chain gene. 
By in situ hybridization analysis, distinct expression was ob- 
served in ependymal embryonic ells lining the ventricular cav- 
ity (Fig. 4C,D) while no expression above background was seen 
in other areas of the brain. In embryonic skin, signals were only 
observed in the dermis (Fig. 4A,B). In neonatal tissues, strong 
expression was observed in mesenchymal perialveolar cells as 
well as in vascular smooth muscle cells (Fig. 5A,B). Alveolar 
epithelia nd endothelial cells were negative. In neonatal skele- 
tal muscle, the muscle fibres themselves did not exhibit expres- 
sion, but interlobular adipous tissue was faintly labeled (Fig. 
5C,D). We did not observe signals above background in neona- 
tal heart of liver tissues. 
The limited availability of human tissues hindered exhaustive 
analysis of the temporal and spatial expression pattern of the 
Fig. 5. In situ hybridization expression analysis of the human laminin ~4 chain in human neonatal lung and muscle tissues. In lung (A,B) mainly 
perialveolar nd vascular smooth muscle cells are labeled, while epithelial pneumocytes and endothelial cells are negative. In muscle (C,D), the muscle 
fibers appear to be negative, while interlobular dipous tissue is fainlty labeled (arrow). 
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laminin c~4 chain. Nevertheless, the expression pattern of this 
laminin chain complements hat of the ctl, ~2 and ~3 [14,48] 
chains. In endothelial cells, the low level o f~ l  or absence ofcz3 
chain expression as detected by immunohistochemistry [48,49] 
and the failure to detect ~1, ~2 or ~4 chains by in situ hybrid- 
ization analysis [14 and this study] might reflect the presence 
of a unique ct chain [26]. The relationship of the ~4 chain to the 
Y shaped laminin produced by adipose cells [50] as well as to 
laminins 6 and 7 [51] in the skin remains to be shown. 
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